마취 및 호흡 기기 시장 보고서 : 제품 유형별, 최종사용자별, 지역별(2025-2033년)

The global anesthesia and respiratory devices market size reached USD 49.7 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 85.4 Billion by 2033, exhibiting a growth rate (CAGR) of 5.88% during 2025-2033. The rising prevalence of respiratory disorders, increasing surgical procedures, expanding aging population, growing healthcare and infrastructure development, and favorable government initiatives and healthcare spending are some of the major factors propelling the market.

Anesthesia and respiratory devices are essential medical equipment used in healthcare settings to facilitate patient care during surgical procedures and manage respiratory conditions. Anesthesia devices are designed to administer general anesthesia to patients, inducing temporary loss of sensation and consciousness, enabling painless surgery. These devices typically include anesthesia machines, vaporizers, and various monitoring equipment to ensure patient safety and appropriate dosage administration. On the other hand, respiratory devices are medical tools utilized in the treatment and management of respiratory disorders. They aid in improving breathing and oxygenation for patients with conditions such as chronic obstructive pulmonary disease (COPD), asthma, or acute respiratory distress syndrome (ARDS). Some common respiratory devices include ventilators, continuous positive airway pressure (CPAP) machines, nebulizers, and oxygen concentrators. Ventilators are especially crucial in providing mechanical ventilation support to patients who are unable to breathe adequately on their own. Both anesthesia and respiratory devices play vital roles in modern healthcare, enhancing patient outcomes and improving overall medical care. These devices are subject to stringent regulatory requirements to ensure their safety, efficacy, and quality, and their continuous development and innovation contribute significantly to advancing medical practices and patient well-being.

The rising incidence of respiratory conditions, including chronic obstructive pulmonary disease (COPD), asthma, and sleep apnea, is a major driver for respiratory devices. These conditions require ongoing monitoring and management, leading to an increased demand for respiratory equipment like oxygen concentrators, nebulizers, and CPAP machines. Additionally, the growing global population, coupled with improved access to healthcare services, has led to a surge in surgical procedures. Anesthesia devices are crucial for ensuring safe and effective anesthesia administration during surgeries, fueling the demand for anesthesia machines, ventilators, and associated equipment. Other than this, the demographic shift towards an aging population has contributed to the rising prevalence of chronic diseases and respiratory disorders. Older adults often require medical interventions, surgeries, and respiratory support, driving the demand for anesthesia and respiratory devices. Besides this, expanding healthcare infrastructure, particularly in emerging economies, has led to increased investments in medical facilities, including hospitals and specialty clinics. This growth in healthcare facilities has bolstered the demand for anesthesia and respiratory equipment to cater to the needs of a larger patient population. Moreover, supportive government policies, investments in healthcare, and insurance coverage for medical treatments have further stimulated the growth of the anesthesia and respiratory market, encouraging higher adoption rates of these devices. Moreover, continuous advancements in medical technology have led to the development of more sophisticated and user-friendly anesthesia and respiratory devices. Innovations such as advanced ventilators with improved patient monitoring capabilities, anesthesia machines with enhanced precision and safety features, and portable respiratory devices have increased their adoption and demand.

Anesthesia and Respiratory Devices Market Trends/Drivers:

Technological Advancements

Technological advancements have revolutionized the anesthesia and respiratory market by introducing innovative devices with enhanced capabilities. For instance, advanced anesthesia machines now offer integrated touchscreen interfaces, real-time data monitoring, and automated drug delivery systems, improving precision and patient safety during surgery. Similarly, respiratory devices have seen remarkable progress, with portable oxygen concentrators enabling patients to maintain mobility while receiving continuous oxygen therapy. Additionally, smart ventilators equipped with advanced algorithms can adapt to patients' changing respiratory needs, providing personalized care. These technological improvements not only enhance the efficiency and efficacy of anesthesia and respiratory treatments but also contribute to better patient outcomes and reduced recovery times, driving the adoption of these devices by healthcare providers globally.

Rising Prevalence of Respiratory Disorders

The escalating prevalence of respiratory disorders has significantly impacted the anesthesia and respiratory market. Chronic respiratory conditions like COPD, asthma, and sleep apnea affect millions of people worldwide. Consequently, the demand for respiratory devices such as nebulizers, CPAP machines, and BiPAP machines has surged to manage these chronic conditions effectively. Moreover, environmental factors, pollution, and lifestyle changes have contributed to an increase in the number of respiratory disorder cases, further fueling the market's growth. Manufacturers are investing in research and development to create advanced respiratory devices that offer improved patient comfort and better disease management, catering to the escalating demand for such solutions.

Expanding Aging Population

The aging global population is a key driver of the anesthesia and respiratory market. With a higher number of elderly individuals, the prevalence of age-related health issues, including respiratory diseases, has risen. Older adults often require surgical interventions, leading to an increased demand for anesthesia machines to provide safe and precise anesthesia delivery. Furthermore, as the elderly are more susceptible to respiratory illnesses, there is a growing need for respiratory devices like ventilators and oxygen concentrators to manage their health conditions. Governments and healthcare providers are investing in updating their medical facilities to accommodate the aging population's healthcare needs, further propelling the demand for anesthesia and respiratory equipment. This demographic shift is expected to sustain the market's growth trajectory in the coming years.

Anesthesia and Respiratory Devices Industry Segmentation:

Breakup by Product Type:

• Anesthesia Devices
• Anesthesia Delivery Machines
• Anesthesia Disposables and Accessories
• Anesthesia Monitors
• Anesthesia Information Management Systems
• Respiratory Devices
• Therapeutic Devices
• Masks
• Ventilators
• Nebulizers
• Humidifiers
• Oxygen Concentrators
• Inhalers
• Reusable Resuscitators
• Nitric Oxide Delivery Units
• Capnographs
• Gas Analyzers
• Oxygen Hoods
• Monitoring Devices
• Diagnostic Devices
• Spirometers
• Polysomnography (PSG) Devices
• Peak Flow Meters
• Consumables and Accessories
• Disposable Resuscitators
• Tracheostomy Tubes
• Nasal Cannulas
• Disposable Masks
• Others

Respiratory devices dominate the market

The rising prevalence of respiratory disorders globally has significantly increased the demand for respiratory devices. Conditions such as chronic obstructive pulmonary disease (COPD), asthma, and sleep apnea affect a large portion of the population, necessitating continuous monitoring and treatment, thereby boosting the market for respiratory devices. Additionally, advancements in medical technology have led to the development of more sophisticated and efficient respiratory devices. These innovations have improved patient comfort, ease of use, and treatment outcomes, driving healthcare providers to adopt the latest respiratory equipment, further contributing to the segment's growth. Other than this, with the aging population on the rise, the incidence of respiratory diseases is also increasing. Older adults are more susceptible to respiratory conditions, requiring respiratory devices for proper disease management and oxygen support. This demographic trend has significantly expanded the market for respiratory devices. Moreover, the ongoing COVID-19 pandemic has further accelerated the demand for respiratory devices like ventilators to provide life-saving respiratory support for critically ill patients, underscoring the critical role these devices play in managing respiratory distress.

Breakup by End User:

• Hospitals
• Clinics
• Homecare Settings
• Ambulatory Service Centers

Hospitals hold the largest share in the market

Hospitals serve as primary centers for providing advanced medical care, including surgeries, critical care, and specialized treatments. These medical facilities require a wide array of anesthesia and respiratory devices to cater to the diverse needs of patients across various medical disciplines. From anesthesia machines for surgical procedures to ventilators for patients in intensive care units, hospitals rely heavily on these devices to ensure optimal patient outcomes. Additionally, hospitals typically have a high patient throughput, admitting a large number of individuals requiring medical attention daily. This consistent flow of patients necessitates a substantial demand for anesthesia and respiratory devices to support their medical needs, contributing to the segment's size. Other than this, hospitals often have well-established budgets for medical equipment procurement, allowing them to invest in modern and technologically advanced anesthesia and respiratory devices. These devices play a critical role in enhancing patient care, leading hospitals to prioritize their acquisition. Furthermore, the ongoing pandemic situations, like COVID-19, have emphasized the need for well-equipped hospitals with an adequate supply of respiratory devices like ventilators to manage respiratory distress in critically ill patients. This further reinforces the hospitals' significance as the largest end-user segment in the anesthesia and respiratory market.

Breakup by Region:

• North America
• United States
• Canada
• Asia-Pacific
• China
• Japan
• India
• South Korea
• Australia
• Indonesia
• Others
• Europe
• Germany
• France
• United Kingdom
• Italy
• Spain
• Russia
• Others
• Latin America
• Brazil
• Mexico
• Others
• Middle East and Africa

North America exhibits a clear dominance in the market

The report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America was the largest market for anesthesia and respiratory devices.

North America has a well-established and advanced healthcare infrastructure, with a high number of hospitals, specialty clinics, and medical facilities. This extensive healthcare network leads to a significant demand for anesthesia and respiratory devices to support the diverse medical needs of patients. Additionally, the region has a substantial elderly population, and with aging comes an increased prevalence of respiratory conditions and the need for surgical interventions, further driving the demand for these devices. Moreover, the region's strong emphasis on research and development in the medical technology sector has led to continuous innovation and the introduction of cutting-edge anesthesia and respiratory devices. This culture of technological advancement and early adoption of new medical equipment contributes to the market's growth. Besides this, factors such as favorable government initiatives, high healthcare expenditure, and insurance coverage facilitate greater accessibility to advanced medical treatments, including anesthesia and respiratory care, further propelling the market in North America. Furthermore, the outbreak of global health crises, such as the COVID-19 pandemic, has highlighted the critical importance of having a robust supply of respiratory devices like ventilators, elevating the demand for these devices in the region.

Competitive Landscape:

Leading companies in the anesthesia and respiratory devices market invest significantly in research and development to introduce innovative products with advanced features. These innovations aim to improve patient outcomes, enhance user experience, and address specific medical challenges. For example, companies may develop anesthesia machines with integrated patient monitoring systems, smart ventilation modes, or respiratory devices with better portability and user-friendly interfaces. By continuously introducing cutting-edge technologies, key players can attract more customers, gain a competitive edge, and drive market growth. Additionally, collaborations and partnerships with other healthcare companies, research institutions, or technology firms are common strategies employed by key players in the anesthesia and respiratory devices market. These partnerships facilitate the exchange of knowledge, expertise, and resources, leading to the development of innovative solutions. For instance, a medical device manufacturer may collaborate with a software company to integrate artificial intelligence algorithms into their devices for enhanced diagnostics and personalized treatments. Such strategic alliances enable companies to leverage each other's strengths and expand their product portfolio, leading to increased market presence and revenue growth. Other than this, in order to tap into emerging markets and cater to the growing demand for anesthesia and respiratory devices, key players often focus on expanding their geographic reach. This expansion may involve establishing new distribution channels, setting up local manufacturing facilities, or acquiring regional companies to gain a foothold in specific markets. By penetrating new regions, companies can access a larger customer base, better understand local requirements, and adapt their products to meet diverse healthcare needs, ultimately driving market growth.

The market research report has provided a comprehensive analysis of the competitive landscape in the market. Detailed profiles of all major companies have also been provided. Some of the key players in the market include:

• 3M Company
• Becton, Dickinson and Company
• Dragerwerk AG & Co. KGaA
• Fisher & Paykel Healthcare Corporation Limited
• GE HealthCare (General Electric)
• Getinge AB
• Hamilton Medical (Hamilton Bonaduz AG)
• ICU Medical Inc.
• Koninklijke Philips N.V.
• Masimo Corporation
• Medtronic plc
• SunMed LLC
• Teleflex Incorporated

Key Questions Answered in This Report

• 1.What was the size of the anesthesia and respiratory devices market in 2024?
• 2.What is the expected growth rate of the global anesthesia and respiratory devices market during 2025-2033?
• 3.What are the key factors driving the global anesthesia and respiratory devices market?
• 4.What has been the impact of COVID-19 on the global anesthesia and respiratory devices market?
• 5.What is the breakup of the global anesthesia and respiratory devices market based on the product type?
• 6.What is the breakup of the global anesthesia and respiratory devices market based on the end user?
• 7.What are the key regions in the global anesthesia and respiratory devices market?
• 8.Who are the key players/companies in the global anesthesia and respiratory devices market?

Table of Contents

1 Preface

2 Scope and Methodology

• 2.1 Objectives of the Study
• 2.2 Stakeholders
• 2.3 Data Sources
  • 2.3.1 Primary Sources
  • 2.3.2 Secondary Sources
• 2.4 Market Estimation
  • 2.4.1 Bottom-Up Approach
  • 2.4.2 Top-Down Approach
• 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

• 4.1 Overview
• 4.2 Key Industry Trends

5 Global Anesthesia and Respiratory Devices Market

• 5.1 Market Overview
• 5.2 Market Performance
• 5.3 Impact of COVID-19
• 5.4 Market Forecast

6 Market Breakup by Product Type

• 6.1 Anesthesia Devices
  • 6.1.1 Market Trends
  • 6.1.2 Key Segments
    • 6.1.2.1 Anesthesia Delivery Machines
    • 6.1.2.2 Anesthesia Disposables and Accessories
    • 6.1.2.3 Anesthesia Monitors
    • 6.1.2.4 Anesthesia Information Management Systems
  • 6.1.3 Market Forecast
• 6.2 Respiratory Devices
  • 6.2.1 Market Trends
  • 6.2.2 Key Segments
    • 6.2.2.1 Therapeutic Devices
    • 6.2.2.2 Masks
    • 6.2.2.3 Ventilators
    • 6.2.2.4 Nebulizers
    • 6.2.2.5 Humidifiers
    • 6.2.2.6 Oxygen Concentrators
    • 6.2.2.7 Inhalers
    • 6.2.2.8 Reusable Resuscitators
    • 6.2.2.9 Nitric Oxide Delivery Units
    • 6.2.2.10 Capnographs
    • 6.2.2.11 Gas Analyzers
    • 6.2.2.12 Oxygen Hoods
  • 6.2.3 Market Forecast
• 6.3 Monitoring Devices
  • 6.3.1 Market Trends
  • 6.3.2 Market Forecast
• 6.4 Diagnostic Devices
  • 6.4.1 Market Trends
  • 6.4.2 Key Segments
    • 6.4.2.1 Spirometers
    • 6.4.2.2 Polysomnography (PSG) Devices
    • 6.4.2.3 Peak Flow Meters
  • 6.4.3 Market Forecast
• 6.5 Consumables and Accessories
  • 6.5.1 Market Trends
  • 6.5.2 Key Segments
    • 6.5.2.1 Disposable Resuscitators
    • 6.5.2.2 Tracheostomy Tubes
    • 6.5.2.3 Nasal Cannulas
    • 6.5.2.4 Disposable Masks
    • 6.5.2.5 Others
  • 6.5.3 Market Forecast

7 Market Breakup by End User

• 7.1 Hospitals
  • 7.1.1 Market Trends
  • 7.1.2 Market Forecast
• 7.2 Clinics
  • 7.2.1 Market Trends
  • 7.2.2 Market Forecast
• 7.3 Homecare Settings
  • 7.3.1 Market Trends
  • 7.3.2 Market Forecast
• 7.4 Ambulatory Service Centers
  • 7.4.1 Market Trends
  • 7.4.2 Market Forecast

8 Market Breakup by Region

• 8.1 North America
  • 8.1.1 United States
    • 8.1.1.1 Market Trends
    • 8.1.1.2 Market Forecast
  • 8.1.2 Canada
    • 8.1.2.1 Market Trends
    • 8.1.2.2 Market Forecast
• 8.2 Asia-Pacific
  • 8.2.1 China
    • 8.2.1.1 Market Trends
    • 8.2.1.2 Market Forecast
  • 8.2.2 Japan
    • 8.2.2.1 Market Trends
    • 8.2.2.2 Market Forecast
  • 8.2.3 India
    • 8.2.3.1 Market Trends
    • 8.2.3.2 Market Forecast
  • 8.2.4 South Korea
    • 8.2.4.1 Market Trends
    • 8.2.4.2 Market Forecast
  • 8.2.5 Australia
    • 8.2.5.1 Market Trends
    • 8.2.5.2 Market Forecast
  • 8.2.6 Indonesia
    • 8.2.6.1 Market Trends
    • 8.2.6.2 Market Forecast
  • 8.2.7 Others
    • 8.2.7.1 Market Trends
    • 8.2.7.2 Market Forecast
• 8.3 Europe
  • 8.3.1 Germany
    • 8.3.1.1 Market Trends
    • 8.3.1.2 Market Forecast
  • 8.3.2 France
    • 8.3.2.1 Market Trends
    • 8.3.2.2 Market Forecast
  • 8.3.3 United Kingdom
    • 8.3.3.1 Market Trends
    • 8.3.3.2 Market Forecast
  • 8.3.4 Italy
    • 8.3.4.1 Market Trends
    • 8.3.4.2 Market Forecast
  • 8.3.5 Spain
    • 8.3.5.1 Market Trends
    • 8.3.5.2 Market Forecast
  • 8.3.6 Russia
    • 8.3.6.1 Market Trends
    • 8.3.6.2 Market Forecast
  • 8.3.7 Others
    • 8.3.7.1 Market Trends
    • 8.3.7.2 Market Forecast
• 8.4 Latin America
  • 8.4.1 Brazil
    • 8.4.1.1 Market Trends
    • 8.4.1.2 Market Forecast
  • 8.4.2 Mexico
    • 8.4.2.1 Market Trends
    • 8.4.2.2 Market Forecast
  • 8.4.3 Others
    • 8.4.3.1 Market Trends
    • 8.4.3.2 Market Forecast
• 8.5 Middle East and Africa
  • 8.5.1 Market Trends
  • 8.5.2 Market Breakup by Country
  • 8.5.3 Market Forecast

9 SWOT Analysis

• 9.1 Overview
• 9.2 Strengths
• 9.3 Weaknesses
• 9.4 Opportunities
• 9.5 Threats

10 Value Chain Analysis

11 Porters Five Forces Analysis

• 11.1 Overview
• 11.2 Bargaining Power of Buyers
• 11.3 Bargaining Power of Suppliers
• 11.4 Degree of Competition
• 11.5 Threat of New Entrants
• 11.6 Threat of Substitutes

12 Price Analysis

13 Competitive Landscape

• 13.1 Market Structure
• 13.2 Key Players
• 13.3 Profiles of Key Players
  • 13.3.1 3M Company
    • 13.3.1.1 Company Overview
    • 13.3.1.2 Product Portfolio
  • 13.3.2 Becton, Dickinson and Company
    • 13.3.2.1 Company Overview
    • 13.3.2.2 Product Portfolio
  • 13.3.3 Dragerwerk AG & Co. KGaA
    • 13.3.3.1 Company Overview
    • 13.3.3.2 Product Portfolio
  • 13.3.4 Fisher & Paykel Healthcare Corporation Limited
    • 13.3.4.1 Company Overview
    • 13.3.4.2 Product Portfolio
  • 13.3.5 GE HealthCare (General Electric)
    • 13.3.5.1 Company Overview
    • 13.3.5.2 Product Portfolio
  • 13.3.6 Getinge AB
    • 13.3.6.1 Company Overview
    • 13.3.6.2 Product Portfolio
  • 13.3.7 Hamilton Medical (Hamilton Bonaduz AG)
    • 13.3.7.1 Company Overview
    • 13.3.7.2 Product Portfolio
  • 13.3.8 ICU Medical Inc.
    • 13.3.8.1 Company Overview
    • 13.3.8.2 Product Portfolio
  • 13.3.9 Koninklijke Philips N.V.
    • 13.3.9.1 Company Overview
    • 13.3.9.2 Product Portfolio
  • 13.3.10 Masimo Corporation
    • 13.3.10.1 Company Overview
    • 13.3.10.2 Product Portfolio
  • 13.3.11 Medtronic plc
    • 13.3.11.1 Company Overview
    • 13.3.11.2 Product Portfolio
  • 13.3.12 SunMed LLC
    • 13.3.12.1 Company Overview
    • 13.3.12.2 Product Portfolio
  • 13.3.13 Teleflex Incorporated
    • 13.3.13.1 Company Overview
    • 13.3.13.2 Product Portfolio